posted on 2019-04-30, 00:00authored byLiang Chi, Pengcheng Tu, Chih-wei Liu, Yunjia Lai, Jingchuan Xue, Hongyu Ru, Kun Lu
Chronic
arsenic exposure from drinking water is a global public
health issue, which is associated with numerous human diseases and
influences millions of people worldwide. The effects of arsenic exposure
to the metabolic networks remain elusive. Here, we exposed female
C57BL/6J mice to 1 ppm inorganic arsenic in drinking water for 3 months
to investigate how arsenic exposure perturbs serum and fecal metabolic
profiles. We found decreased levels of serum compounds with antioxidative
activities in arsenic-treated mice, in accordance with elevated oxidative
stress indicated by higher urinary 8-oxo-2′-deoxyguanosine
(8-oxo-dG) levels. Moreover, the levels of multiple lysophosphatidylcholines
(lysoPCs) were significantly increased in the sera of arsenic-exposed
mice, including lysoPC (O-18:0), lysoPC (20:3), lysoPC (18:1), and
lysoPC (22:6). Arsenic exposure perturbed the levels of several key
polyunsaturated fatty acids (PUFAs) in the fecal samples in concert
with alterations in related microbial pathways. Additionally, changes
in the abundances of many functional metabolites, together with decreased
levels of amino acids, were found in the fecal samples of arsenic-treated
mice. By delineating the impact of arsenic exposure on the metabolic
profiles, the findings may provide new biomarkers and mechanistic
insights into arsenic-associated diseases.